Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo.
Cannabis News
India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites
India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites.
Global Payout, Inc. (GOHE) Subsidiary Secures Definitive Referral Partnership Agreement with GreenRush Group, Inc.
Global Payout (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”) has entered a definitive Referral Partnership Agreement with GreenRush Group, Inc.
P.E.I. sets legal age for pot at 19, to be sold in government-owned stores and online
Legislation is expected to come into effect July 1, 2018.
DOJA Cannabis Announces $15 Million Bought Deal Private Placement of Convertible Debenture Units
DOJA Cannabis Company Limited (CSE:DOJA) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, 15,000 units of the Company
Delta 9 Announces C$20.0 Million Bought Deal
DELTA 9 CANNABIS INC. (TSXV: NINE) announces that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. to purchase 7.4Million shares at $2.70 on a bought deal.
MANITOBA INTRODUCES MEASURES TO RESPONSIBLY CONTROL RETAIL SALES OF CANNABIS
Regulations Announced to Keep Cannabis Out of the Hands of Youth, Away from Black Market: Stefanson-
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management
One pioneering biopharmaceutical company, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), has triggered a paradigm shift in discovering potential breakthrough cannabinoid-based therapies. .-
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Featured in Visual Capitalist Company Spotlight
Among other areas of interest, Visual Capitalist provided an in-depth look into InMed’s Bioinformatics assessment tool, Biosynthesis cannabinoid manufacturing process, and drug pipeline of new cannabinoid treatments.
GW Pharma to Raise up to $258.75 Million in Underwritten Deal
GWPH announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering.-
SinglePoint, Inc. (SING) Inks LOI Formalizing Joint Venture with Smart Cannabis Corp. (SCNA)
SinglePoint (OTC: SING) and Smart Cannabis (OTC: SCNA) have signed a Letter of Intent (“LOI”) to formalize a joint venture relationship.
Aphria enters into supplier agreement with Shoppers Drug Mart
Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. -
Veritas Pharma Inc.’s (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Cannevert Subsidiary Inks Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico
Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) today announced that its research arm, Cannevert Therapeutics Ltd. (“CTL”), has signed a Material Transfer Agreement with the Institute for Medical Cannabis Corporation of Puerto Rico.
Purified Cannabinoids Open New Opportunities in Pain Management
As consumer acceptance continues to propel demand to unprecedented levels, companies such as InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) are making waves in the advancement of cannabinoid compounds as a medical solution in pain management and other indications.-
B.C. releases first decisions on cannabis regulation after public engagement
After considering input from 48,951 British Columbians, and submissions from 141 local and Indigenous governments and a range of other interested stakeholders, the Province has announced a number of key decisions related to the anticipated legalization of non-medical cannabis in July 2018.-